Hiroshi Kobayashi Selected Research

Hiroshi Kobayashi Research Topics

Disease

127	Neoplasms (Cancer) 11/2023 - 08/2002
50	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 08/2002
48	Neoplasm Metastasis (Metastasis) 01/2024 - 03/2003
42	Endometriosis 01/2024 - 01/2009
27	Carcinoma (Carcinomatosis) 11/2023 - 04/2003
26	Inflammation (Inflammations) 04/2024 - 05/2003
23	Carcinogenesis 03/2022 - 07/2002
17	Hemorrhage 08/2023 - 10/2008
12	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 09/2004
11	Mucopolysaccharidosis II (Hunter Syndrome) 05/2021 - 09/2012
10	Pain (Aches) 04/2024 - 09/2010
10	Pre-Eclampsia (Preeclampsia) 04/2023 - 09/2009
10	Glycogen Storage Disease Type II (Pompe's Disease) 01/2017 - 05/2010
9	Hypoxia (Hypoxemia) 01/2024 - 09/2009
9	Ovarian Epithelial Carcinoma 02/2022 - 08/2012
8	Adenomyosis 01/2023 - 03/2013
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2019 - 06/2010
7	Endometrial Neoplasms (Endometrial Cancer) 06/2018 - 11/2002
7	Hypersensitivity (Allergy) 01/2016 - 05/2009
6	Menstruation Disturbances 02/2024 - 08/2009
6	Wounds and Injuries (Trauma) 01/2024 - 10/2009
6	Cysts 12/2021 - 07/2012
6	Lysosomal Storage Diseases (Lysosomal Storage Disease) 05/2021 - 05/2014
6	Mesothelioma 03/2013 - 11/2010
6	Open-Angle Glaucoma (Glaucoma, Open Angle) 08/2012 - 05/2003
5	Infections 04/2024 - 05/2009
5	Stomach Neoplasms (Stomach Cancer) 12/2022 - 02/2010
5	Rheumatoid Arthritis 01/2022 - 07/2003
5	Residual Neoplasm 01/2022 - 03/2005
5	Fibrosis (Cirrhosis) 01/2020 - 05/2003
5	Osteoarthritis 01/2020 - 10/2013
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2017 - 04/2012
5	Premature Obstetric Labor (Premature Labor) 07/2016 - 01/2011
5	Hypertension (High Blood Pressure) 04/2014 - 09/2007
5	Chondrosarcoma 11/2005 - 03/2002
4	Infertility (Sterility) 05/2023 - 01/2022
4	Pancreatic Neoplasms (Pancreatic Cancer) 03/2023 - 11/2010
4	Female Genital Diseases 01/2023 - 03/2005
4	Disease Progression 11/2022 - 10/2018
4	Fabry Disease (Fabry's Disease) 06/2022 - 05/2011
4	Ascites 01/2022 - 05/2004
4	Spontaneous Fractures (Pathological Fracture) 10/2020 - 09/2010

Drug/Important Bio-Agent (IBA)

39	Proteins (Proteins, Gene)FDA Link 09/2022 - 08/2002
26	IronIBA 01/2024 - 10/2008
23	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2022 - 03/2002
18	CytokinesIBA 01/2021 - 04/2003
17	Protease Inhibitors (Protease Inhibitor)IBA 01/2013 - 03/2002
15	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2005
14	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2023 - 08/2009
14	GlycosaminoglycansIBA 05/2021 - 05/2005
13	Heme (Haem)IBA 12/2021 - 10/2008
13	Messenger RNA (mRNA)IBA 07/2018 - 08/2002
12	EnzymesIBA 08/2023 - 09/2002
11	AntioxidantsIBA 03/2022 - 03/2006
10	Phosphotransferases (Kinase)IBA 01/2023 - 12/2002
10	GlucosidasesIBA 10/2022 - 11/2011
10	Transcription Factors (Transcription Factor)IBA 04/2018 - 04/2003
10	LigandsIBA 09/2017 - 08/2009
9	AcidsIBA 10/2022 - 11/2011
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2010
8	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2015
8	Urokinase Plasminogen Activator ReceptorsIBA 01/2022 - 08/2002
8	ErbB Receptors (EGF Receptor)IBA 01/2020 - 12/2010
8	Peptide Hydrolases (Proteases)FDA Link 08/2015 - 04/2003
7	Estrogens (Estrogen)FDA Link 01/2023 - 10/2011
7	tissue-factor-pathway inhibitor 2 (PP5)IBA 09/2022 - 08/2015
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2011 - 11/2004
6	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2005 - 07/2003
5	RNA (Ribonucleic Acid)IBA 01/2023 - 04/2012
5	C-Reactive ProteinIBA 01/2023 - 01/2015
5	Paclitaxel (Taxol)FDA LinkGeneric 11/2022 - 05/2004
5	AntigensIBA 09/2022 - 08/2015
5	fibrin fragment D (D-dimer)IBA 02/2022 - 04/2012
5	Hormones (Hormone)IBA 12/2021 - 01/2011
5	PlatinumIBA 11/2021 - 02/2012
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2018 - 08/2005
5	LipopolysaccharidesIBA 01/2016 - 03/2005
5	Hepatocyte Nuclear FactorsIBA 11/2013 - 10/2011
4	Fibrinolysin FDA Link 11/2023 - 04/2003
4	Thromboplastin (Tissue Factor)IBA 07/2023 - 08/2015
4	Histones (Histone)IBA 02/2023 - 10/2011
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2021
4	Carboplatin (JM8)FDA LinkGeneric 11/2022 - 07/2006
4	Plasminogen InactivatorsIBA 01/2022 - 07/2003
4	Estrogen ReceptorsIBA 03/2021 - 08/2002
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 04/2014
4	Indicators and Reagents (Reagents)IBA 01/2021 - 09/2004
4	Therapeutic UsesIBA 12/2020 - 01/2013
4	Dihydrotachysterol (AT 10)IBA 05/2020 - 08/2005

Therapy/Procedure

53	Therapeutics 01/2024 - 02/2004
36	Drug Therapy (Chemotherapy) 01/2024 - 09/2004
18	Radiotherapy 01/2023 - 09/2010
12	Enzyme Replacement Therapy 12/2020 - 05/2010
9	Hysterectomy 01/2020 - 10/2007
8	Adjuvant Chemotherapy 05/2022 - 09/2004
6	Curettage 01/2024 - 12/2017
6	Laparotomy 10/2022 - 04/2013
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021 - 05/2011
5	Aftercare (After-Treatment) 03/2023 - 06/2010
5	Gastrectomy 12/2022 - 02/2010